Rob Stein Rob Stein is a Correspondent and Senior Editor on NPR's Science Desk.
Maggie Starbard/NPR
Rob Stein
Maggie Starbard/NPR

Rob Stein

Correspondent and Senior Editor, Science Desk

Rob Stein is a correspondent and senior editor on NPR's science desk.

An award-winning science journalist with more than 25 years of experience, Stein mostly covers health and medicine. He tends to focus on stories that illustrate the intersection of science, health, politics, social trends, ethics, and federal science policy. He tracks genetics, stem cells, cancer research, women's health issues and other science, medical, and health policy news.

Before NPR, Stein worked at The Washington Post for 16 years, first as the newspaper's science editor and then as a national health reporter. Earlier in his career, Stein spent about four years as an editor at NPR's science desk. Before that, he was a science reporter for United Press International (UPI) in Boston and the science editor of the international wire service in Washington.

Stein is a graduate of the University of Massachusetts, Amherst. He completed a journalism fellowship at the Harvard School of Public Health, a program in science and religion at the University of Cambridge, and a summer science writer's workshop at the Marine Biological Laboratory in Woods Hole, Mass.

Stein's work has been honored by many organizations, including the National Academy of Sciences, the American Association for the Advancement of Science and the Association of Health Care Journalists.

[+] read more[-] less

Story Archive

Shaorong Deng gets an experimental treatment for cancer of the esophagus that uses his own immune system cells. They have been genetically modified with the gene-editing technique known as CRISPR. Yuhan Xu/NPR hide caption

toggle caption
Yuhan Xu/NPR

Doctors In China Lead Race To Treat Cancer By Editing Genes

  • Download
  • <iframe src="https://www.npr.org/player/embed/585336506/587502704" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript

Philip Morris' iQOS device heats tobacco but stops short of burning it, an approach the company says reduces exposure to tar and other toxic byproducts of burning cigarettes. Philip Morris via AP hide caption

toggle caption
Philip Morris via AP

FDA Panel Gives Qualified Support To Claims For 'Safer' Smoking Device

  • Download
  • <iframe src="https://www.npr.org/player/embed/580213742/580827335" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript

Zhong Zhong (left) and Hua Hua are the first primate clones made by somatic cell nuclear transfer, the same process that created Dolly the sheep in 1996. Qiang Sun and Mu-ming Poo/Chinese Academy of Sciences/Cell Press hide caption

toggle caption
Qiang Sun and Mu-ming Poo/Chinese Academy of Sciences/Cell Press

Chinese Scientists Clone Monkeys Using Method That Created Dolly The Sheep

  • Download
  • <iframe src="https://www.npr.org/player/embed/579925801/580433807" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript

Flu patient Donnie Cardenas waits in an emergency room hallway with roommate Torrey Jewett at the Palomar Medical Center in Escondido, Calif., this past week. Gregory Bull/AP hide caption

toggle caption
Gregory Bull/AP

Flu Season Is Shaping Up To Be A Nasty One, CDC Says

  • Download
  • <iframe src="https://www.npr.org/player/embed/577632089/577713388" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript

Gene Editing Experiments In Mice May Help People Hear Too

  • Download
  • <iframe src="https://www.npr.org/player/embed/573142662/573142663" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript

Life expectancy in the U.S. has fallen for the second straight year, in part because of the surge of overdoses on opioids, such as oxycodone. John Moore/Getty Images hide caption

toggle caption
John Moore/Getty Images

Life Expectancy Drops Again As Opioid Deaths Surge In U.S.

  • Download
  • <iframe src="https://www.npr.org/player/embed/572080314/572535026" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript

Scientists Use Gene Editing To Prevent A Form Of Deafness In Mice

  • Download
  • <iframe src="https://www.npr.org/player/embed/571208704/572376207" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript

This Food and Drug Administration approved Luxturna, a gene therapy developed by Spark Therapeutics, to treat an inherited form of blindness. Courtesy of Spark Therapeutics via AP hide caption

toggle caption
Courtesy of Spark Therapeutics via AP

The Food and Drug Administration plans to take action against risky homeopathic remedies under a policy unveiled Monday. Alexander Baumann/EyeEm/Getty Images hide caption

toggle caption
Alexander Baumann/EyeEm/Getty Images

Food And Drug Administration Plans Crackdown On Risky Homeopathic Remedies

  • Download
  • <iframe src="https://www.npr.org/player/embed/571666553/571735730" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript

Could Probiotics Protect Kids From A Downside Of Antibiotics?

  • Download
  • <iframe src="https://www.npr.org/player/embed/567746569/578817059" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript

Australia had a particularly hard flu season this year, which may predict similar challenges for the U.S. Pascal Pochard-Casabianca/AFP/Getty Images hide caption

toggle caption
Pascal Pochard-Casabianca/AFP/Getty Images

In The U.S., Flu Season Could Be Unusually Harsh This Year

  • Download
  • <iframe src="https://www.npr.org/player/embed/569379155/569983815" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript